There is an increasing body of evidence, including that from prospective population studies and epidemiological observational studies, suggesting a strong inverse relationship between increased consumption of wholegrain foods and reduced risk of CVD. This evidence has translated into specific dietary recommendations in the USA to consume at least three servings of whole grain per d, and has informed the development of specific health claims for wholegrain foods both in the USA and in Europe. Wholegrain foods are rich sources of many nutrients and phytochemicals, including complex carbohydrates, dietary fibre, minerals, vitamins, antioxidants and phyto-oestrogens such as lignans. Many of these components are lost from the grain during processing and although some may be replaced (such as in the mandatory fortification of white flour), this practice ignores the possible synergistic effects of the 'natural' constituents. The notion that wholegrain foods are simply a source of dietary fibre has been dispelled, although the additional components that contribute to the health benefits have not been clearly identified. In addition, the mechanisms by which wholegrain foods may have their effect are poorly understood. At present there are few strictly-controlled intervention studies that have confirmed a beneficial effect of increased consumption of wholegrain foods, demonstrated the level of consumption required to elicit a beneficial effect or provided evidence of modes of action. Although wholegrain foods are considered amongst the healthiest food choices available, their consumption falls well below current recommendations, which have been based mainly on epidemiological evidence. Well-controlled intervention studies are needed to provide more detailed mechanistic evidence to support the health claims and findings which can be used to develop effective public health strategies to promote whole-grain consumption.
Whole grain: CVD: Antioxidants: Disease risk
Whole grains
Whole grains as foods in the human diet are not a new invention. Evidence of their consumption can be found in ancient petroglyphs and remains have been found in preserved coprolites. Stable-isotope signatures in hair from 5200-year-old Ice Man are consistent with the consumption of vegetarian diets based on C 3 plants (Macko et al. 1999) . Until relatively recent history grains were crushed and 'milled' to produce coarse flours and were essentially consumed as 'whole grains', with a poor and incomplete separation of the bran and germ from the endosperm. With the development of the roller mill separation became more efficient, and since that time consumption of refined grains has increased dramatically, especially in Western industrialised countries, almost to the exclusion of whole grains. Consumption of whole grains has increased slightly since the 1970s when the 'fibre hypothesis' promoted the potential health benefits of fibre-rich foods, including those derived from whole cereal grains (Trowell, 1979) .
The cereal grains consumed by man are the seeds of the Gramineae family of grasses. The most commonly consumed are wheat, rice and maize, although barley, oats, rye, millet and sorghum are more common in some countries than in others depending on climate and cultural differences (Southgate, 2000) . Whole grains are composed of three principal parts, the bran, the germ and the endosperm; the relative amounts of these constituents differ from one species to another. For example, brown rice has a very low bran content (30 mg/g) compared with maize (approximately 60 mg/g) and wheat (£160 mg/g). Similarly, the soluble fibre content of oats, barley and rye is much higher than that found in wheat. Bran and germ contain many nutrients, and non-nutrient inorganic and organic components, many of which are lost during the refining process; the extent of the loss depends on the extent of extraction (Smith et al. 2003) . Although some of these constituents can be replaced into the refined flour through mandatory fortification policies, there is a consensus view (Pereira et al. 2001; Slavin, 2003) that suggests that consumption of the fortified product is not the same as consumption of the original grain product with its more complex structure. In the majority of modern milling practices the individual components of the grain are separated but then re-constituted to re-form the wholegrain (wholemeal) flour. The American Association of Cereal Chemists have sought to produce a definition of whole grain that will be of benefit to consumers and food manufacturers. The definition, which was approved and adopted in 1999, is: 'Whole grains shall consist of the intact, ground, cracked or flaked caryopsis, whose principal anatomical components -the starchy endosperm, germ and bran -are present in the same relative proportions as they exist in the intact caryopsis' (American Association of Cereal Chemists, 2005) .
It is important to note that wholegrain foods are not 'unprocessed'; the average consumer does not eat intact whole grains except in small quantities in some mueslis or when added as texture in some breads. Grains are altered mostly during milling in order to improve flavour, colour, palatability, appearance and cooking characteristics as well as to provide shelf-stable products. It is unusual to consume wholegrain flours in which the constituent parts have not been separated during the milling process, with the exception generally of stoneground or specialist flours. In addition, flours themselves are subjected to considerable shear forces during milling. This, together with the fractionation and re-constitution procedures will, inevitably, result in changes to the gross morphology of the product and most likely the chemical composition.
Definition of wholegrain foods and health claims
The US Food and Drug Administration was the first authority to allow a health claim based on wholegrain foods, which was approved by Congress in 1999 under the Food and Drug Administration Modernisation Act (Wiemer, 2002) . The health claim was approved as an 'authoritative statement' following an industry-led submission by General Mills (Minneapolis, MN, USA) and reads as follows: 'Diets rich in wholegrain foods and other plant foods and low in total fat, saturated fat, and cholesterol may reduce the risk of heart disease and some cancers ' (Food and Drug Administration, 1999) . A second, modified, health claim was approved in 2003 (Food and Drug Administration, 2003) . The difference between the two statements is that because fat per se is not associated with increased risk of heart disease (it is the saturated fat and cholesterol that are the problem) foods bearing the second health claim do not need to meet the nutrient content claim of a 'low-fat' food, but can contain moderate levels of fat. The Food and Drug Administration (1999) have defined a wholegrain food as a product containing > 51% whole grain by weight per reference amount customarily consumed per d. In order to use the health claim, and consider the food as a 'wholegrain food', the whole grain ingredients must be present in sufficient quantity to characterise the food (hence the dominant or first ingredient in the ingredient list must be a whole grain), and the food must provide a minimum of 16 g whole grain/reference amount customarily consumed (Richardson, 2003) . Europe has followed the US lead, first with the Joint Health Claims Initiative concluding that 'people with a healthy heart tend to eat more wholegrain foods as part of a healthy lifestyle'. The process leading to this statement, and the evidence considered, has been recently reviewed by Richardson (2003) . The Swedish Nutrition Foundation (2003) issued the stringent, if rather long, statement 'A healthy lifestyle and a well balanced diet rich in wholegrain products reduces the risk for (coronary) heart disease. The product X is rich in wholegrains (contains Y % of wholegrain)'. Thus, although there is considerable evidence that diets rich in wholegrain foods are associated with reduced risk of some cancers and type 2 diabetes, the focus driven through the food industry has been on the association with reduced CVD.
Whole grains and CVD risk, epidemiological and experimental evidence of benefit CVD encompass a range of pathologies, including disease of the arteries supplying blood to the muscles of the heart (CHD or IHD), the brain (cerebrovascular disease or stroke) and the extremities, especially the legs (peripheral vascular disease, e.g. deep-vein thrombosis). The disease involves the processes of atherosclerosis (lesions of the arteries caused by fat deposition), arteriosclerosis (caused by Ca deposition) and thrombosis (blood clotting). Collectively CVD are the most common causes of death in Western countries, accounting for >40% of all deaths. CHD is the single largest cause of death in the UK (British Heart Foundation, 2005) and US (American Heart Association, 2005) . Recognising the protective association between the consumption of wholegrain foods and CVD is not new. Trowell (1972) first proposed that wholegrain foods are protective against IHD, but this proposal has been re-interpreted as a 'fibre' hypothesis rather than a 'highfibre food' hypothesis (Anderson et al. 2000; Anderson, 2004) , with the consequence that 'fibre' has become the focus of public health recommendations rather than placing the emphasis on whole foods. In one of only a small number of studies from the UK Morris et al. (1977) have reported an 80 % reduction in heart attacks in men when those with the highest cereal-fibre intake compared with those with the lowest intakes. Subsequently, a number of large epidemiological and controlled studies, mainly based in the USA, have reported negative associations between whole-grain intake and risk for CHD. These studies have been reviewed by Anderson et al. (2000) , and their analysis has been recently updated by Anderson (2003) . The results of these meta-analyses confirm the suggestion that whole grains are more effective in reducing risk of CVD than other foods commonly eaten such as fruit or vegetables, and that this effect is independent of cereal fibre. Indeed, for cereal fibre alone Anderson (2003) has demonstrated that there is no protective effect against CVD, suggesting that the bran and outer germ are important factors in the protective mechanisms associated with whole grains. A brief summary of the important larger studies is shown in Table 1 . In reporting the effects of wholegrain foods on disease risk it is important to note that whole-grain intake can be a marker of a generally healthier lifestyle, including increased physical activity and lower smoking rates, which are themselves key factors in determining heart disease risk (see Anderson et al. 2000) . Thus, the data shown in Table 1 show the results of full-models adjustments. In all cases the full-models adjustments reduce the significance of the whole-grain effect compared with unadjusted data, but still support the overall observation of reduced risk with increasing wholegrain intake.
In addition to the larger population-based studies there are some smaller studies showing positive effects of increased whole-grain intake on measures of cardiovascular function. For example, Erkkilä et al. (2005) in a study with 229 post-menopausal women with established coronary artery disease have shown that those women consuming more than the median intake of six servings of whole grains per week have a lower decline in minimum coronary artery diameter and show a trend towards lower progression in percent stenosis over a 3-year follow-up. In a smaller study with twenty-one non-hypertensive men Hallfrisch et al. (2003) have reported that consuming high-fibre diets based on insoluble fibre (brown rice and wheat) and/or soluble fibre (barley) results in lowering of systolic, diastolic and mean arterial pressure compared with the Step 1 American Heart Association diet. HR, hazard ratio; RR, relative risk. *Unless otherwise stated HR or RR have been reported using any fully-adjusted model including all adjustments for demographic, dietary and non-dietary factors and the subject numbers shown are the numbers in the adjusted model.
Mechanisms of action
Very few studies have been undertaken on the physiological effects of consuming diets high in wholegrain foods, and thus the mechanisms of action of these products remain somewhat speculative. There are, of course, additional complications associated with unravelling the effects of whole foods compared with single nutrients or pharmacological agents. As discussed previously, whole grains are derived from a range of different species, they are consumed in a variety of different forms and thus they contribute different patterns of nutrients and bio-active compounds to the diet. Thus, it is highly likely that no single component or 'mechanism' will account for their beneficial effects. Rather, it is probably the combination of a range of different synergistic processes that are modulated or improved and result in an overall health benefit.
Antioxidant effects of wholegrain foods
Antioxidants include a wide range of compounds that delay or prevent pro-oxidant-initiated oxidation of substrates and are present in a variety of forms in foodstuffs (Halliwell et al. 1995) . Thus, antioxidants include many molecules such as minerals, vitamins, proteins, carbohydrates and polyphenolics that are capable of donating an electron(s) to a pro-oxidant. Antioxidants in foods may exert their effects in the gut lumen or, once absorbed, in cells and tissues within the body. These 'exogenous' sources of antioxidants contribute to the body's overall antioxidant potential, which also includes 'endogenous' antioxidant molecules and enzymes synthesised within cells in response to oxidative stress. The balance between endogenous and exogenous antioxidants in moderating oxidative stress is a matter of some conjecture, since methods for measuring antioxidant status are very broad in their specificity and cannot distinguish between the different molecular species (Cao & Prior, 1998) . In general, however, avoidance of oxidative stress is important in protecting the body against the consequences of oxidative damage to DNA, proteins and lipids (Sies et al. 2005) . Unsaturated fatty acids incorporated into LDL are very prone to oxidative damage and oxidised LDL are strongly atherogenic. Improvements in antioxidant status and concomitant reduction in LDL oxidation products are therefore important in reducing cardiovascular risk. Whole grains contain many water-soluble and fatsoluble antioxidants, including trace minerals, vitamins, phenolic acids, lignans, phytic acid, tocopherols, tocotrienols and phyto-oestrogens. These antioxidant compounds have been extracted and measured by several methods (Kähkonen et al. 1999; Zielinski & Kozlowska, 2000; Adom & Liu, 2002; Halvorsen et al. 2002) . The majority of the procedures described in these studies rely on the use of solvents to produce an antioxidant extract that clearly demonstrates a range of antioxidant contents for the different products. However, these extraction procedures are essentially 'non-physiological' and do not necessarily reflect the available antioxidant that can be released from the food matrix during passage through the gastrointestinal tract. An in vitro procedure has recently been used to mimic the different phases of digestion through the intestines, using sequential acid, alkali and enzymic steps to provide a more physiological measure of available antioxidant (Nagah & Seal, 2005 ). The results demonstrate that antioxidant release is dependent on the incubation conditions and suggest that as digestion progresses antioxidants can be released from within the food matrix. The apparent antioxidant content of the wholegrain foods is higher than that of refined-grain alternatives, but much lower than that measured in fruits and vegetables (Fig. 1) . Wholegrain foods therefore have potential as sources of antioxidants, but the extent to which their consumption can affect antioxidant status in animals or man is not clear.
The impact of consuming wholegrain products on antioxidant status has been measured using both animals and human subjects. For laboratory rats fed diets containing 500 g wholemeal wheat, wholemeal rye or brown-rice flours/kg for 21 d the plasma antioxidant capacity is not different from that of rats fed a control diet containing 500 g maize starch/kg . The antioxidant content of urine is highest for rats fed wholemeal rye, although the antioxidant content of faeces is similar for rats fed all three wholegrain diets (Fig. 2) , albeit higher than that for the animals fed maize starch. The CHEW-IT study (Jones et al. 2004a,b) was a whole-grain intervention study with human subjects in which participants were asked to consume three 23 g servings of wholegrain food per d for 8 weeks and then increase their wholegrain food consumption to six 23 g servings per d for a further 8 weeks. Fasting blood samples and 24 h urine collections were taken at baseline, 8 and 16 weeks. The antioxidant capacity of plasma shows no difference during the intervention (Fig. 3(a, b) ). However, the antioxidant output in urine increases progressively with increasing wholegrain intakes (Fig. 3(c, d) ). The lack of response in plasma antioxidant measures is disappointing as compliance equivalents (FIE); mM) in some wholegrain foods in comparison with fruit determined using the ferric-reducing activity power assay.
(Data from Nagah & Seal, 2005.) with the intervention was good (AR Jones, S Kuznesof, DP Richardson and CJ Seal, unpublished results), perhaps suggesting that fasting blood samples are not good indicators of antioxidant status in these healthy individuals. In the rat model plasma samples also show no difference despite large intakes of very different wholegrain products. Interestingly, however, urinary antioxidant output in both studies appears to respond to changes in the diet. Increased urinary output may be indicative of watersoluble components that have been absorbed through the gut and then excreted in urine. Transient changes in the antioxidant capacity of plasma have been reported following tea consumption (Langley-Evans, 2000; Leenen et al. 2000) , with maximum values reached approximately 1 h after drinking the tea. In the latter study it was found that antioxidant status measured using the ferric reducing ability of plasma assay continues to rise with hourly tea consumption, but the time taken to return to baseline values was not reported. Consuming meals with wholegrain foods containing higher levels of antioxidants may also result in postprandial fluctuations in apparent antioxidant status and this response would be an area of interest for future research. In addition, the relative insensitivity and lack of specificity of the analytical methods commonly used (the ferric-reducing activity power assay (Benzie & Strain, 1996) and the Trolox equivalent antioxidant capacity method (Re et al. 1999) ) may also mask beneficial effects, and further analysis of specific antioxidant compounds present in wholegrain foods and their absence or presence in plasma will be required in order to determine whether they can make a major contribution to antioxidant status. 
Mammalian lignans and whole grains
The major sources of dietary lignans in human nutrition are the cereals, although fruits and berries also contribute to intake. However, soyabean and flaxseed contain much higher concentrations of lignans than cereals, so intakes can vary greatly between populations for whom these foods are more common in the diet. Within cereals there is also considerable variation in lignan precursors, and rye is particularly high in lignans; thus, populations such as the Finns who consume large quantities of rye products are also likely to have higher intakes.
Lignans are consumed as precursor molecules, predominantly matairesinol and secoisolariciresinol, that are converted to the active mammalian lignans enterolactone and enterodiol by the colonic microflora. With the development of analytical methods for the determination of dietary lignans, the number of precursors identified has increased (Nurmi & Adlercreutz, 1999) . However, the contribution of these precursors to enterolactone and enterodiol concentrations in plasma remains uncertain.
Lignans are potent antioxidant molecules and have been shown to be protective against hormone-related cancers Pietinen & Kilkkinen, 2002; Hallmans et al. 2003; Qu et al. 2005) . In vitro the lignans do not bind to the oestrogen receptor (Saarinen et al. 2000) , but enterolactone inhibits human oestrogen synthetase by binding to the active site of the P 450 enzyme (Adlercreutz et al. 1993) .
Population data on lignan intakes are largely unreliable since the lignan content of many foodstuffs is not known, especially for the newly-identified precursor molecules. Recently, however, analyses based on new foodcomposition data have become available (for example, see Milder et al. 2005) and they show that early estimates considerably underestimated lignan intake. Also, plasma enterolactone and enterodiol concentrations are strongly correlated with intake (Kilkkinen et al. 2001 (Kilkkinen et al. , 2003 Horner et al. 2002; Johnsen et al. 2004) . Furthermore, feeding of wholegrain rye, wheat and brown rice to rats results in higher plasma concentrations and urinary excretion of enterolactone and enterodiol than feeding maize starch (Nagah et al. 2004; , as does feeding wholegrain rye to pigs (Bach Knudsen et al. 2003) . In both animals and human subjects, however, there is considerable intra-individual variability in plasma concentrations, which may be related to the extent of conversion of plant lignan precursors to mammalian lignans, which is strongly dependent on the activity of the gut microflora (Kilkkinen et al. 2001; Grace et al. 2003; Niemeyer et al. 2003) , and the ability to absorb the metabolites (Bowey et al. 2003) . The metabolic consequences of elevated plasma enterolactone and enterodiol concentrations have not been elucidated, and more evidence from human studies is required to confirm whether these molecules are involved in reducing CVD risk and to elucidate their mechanisms of action. It is possible that the lignans may possess similar cardioprotective effects to those reported for other polyphenolic compounds, including reducing LDL-cholesterol oxidation, changes in cholesterol synthesis and re-cycling, and changes in the metabolism of triacylglycerols (Zern & Fernandez, 2005) , although as yet there is limited evidence to support these hypotheses. Men from the Kuopio Ischaemic Heart Disease Risk Factor Study in the highest quartile of serum enterolactone concentrations were found to have a 65 % lower risk of acute coronary events than men from the lowest quartile (Vanharanta et al. 1999) . However, serum total cholesterol and LDL-cholesterol concentrations were not found to be different between the quartiles. In a study of post-menopausal women Kreijkamp-Kaspers et al. (2005) have shown a trend for lower total cholesterol and LDL-cholesterol concentrations across tertiles of lignan intake that again was not significant. In a recent analysis of a subgroup of subjects from the Health Professionals Follow-up Study van der Schouw et al. (2005) have reported that concentrations of LDL-cholesterol and apoB tend to increase across quartiles of increasing lignan intake (for LDL-cholesterol: from quartile 4 to quartile 1, 9%; P = 0 . 01 for trend; for apoB: from quartile 4 to quartile 1, 9%; P = 0 . 02 for trend). However, fasting insulin and C-peptide tend to decrease across quartiles of lignan intake (for insulin: from quartile 4 to quartile 1, -11%; P = 0 . 02 for trend; for C-peptide: from quartile 4 to quartile 1, -25%; P = 0 . 01 for trend). Both these studies have limitations in the quantification of lignan intake, which was calculated from dietary data collected from a food-frequency questionnaire not specifically designed for this purpose, and no measures of lignan 'status' were determined.
Changes in insulin resistance
Insulin resistance and hyperinsulinaemia are associated with increased risk of CVD (Shinozaki et al. 1996; Katz et al. 1999; Golden et al. 2002; Uwaifo & Ratner, 2003) . However, the impact of the source and type of carbohydrate on the development of insulin resistance is inconclusive (Daly et al. 1997) . In a study using laboratory rats Byrnes et al. (1995) have shown that feeding rapidlydigested starch with a high amylopectin content results in increased plasma insulin concentrations following an intravenous glucose challenge. The mechanisms involved in this increase in insulin resistance have not been elucidated, and it is uncertain whether these results can be extrapolated to man. In acute studies starches that are rapidly digested (high glycaemic index; GI) result in higher postprandial glucose and insulin responses compared with starches that are more slowly digested (lower GI; Seal et al. 2003; Ells et al. 2005) . Recurrent postprandial exposure to high plasma glucose and high plasma insulin as a result of habitual consumption of refined high-GI carbohydrate foods may contribute to the development of insulin resistance. Indeed, changing from high-GI foods to low-GI foods has been shown to result in improved insulin sensitivity (for example, see Frost et al. 1998) . Wholegrain foods with intact germ and bran may have lower GI values than foods containing refined carbohydrate (Foster-Powell & Brand-Miller, 1995) . However, grinding or milling cereals during processing removes the bran layer and reduces particle size, allowing more rapid digestion by digestive enzymes, and thus wholegrain foods do not necessarily have a lower GI. It would be expected, however, that diets rich in wholegrain foods may result in improved insulin sensitivity, and there is some evidence to support this hypothesis from epidemiological studies that have demonstrated associations between lower fasting insulin concentrations and glycaemic response and increased consumption of whole grains (Pereira et al. 1998; Fung et al. 2002) . In one study in which insulin sensitivity was measured by intravenous glucose-tolerance test Liese et al. (2003) have shown an increase in insulin sensitivity with increased whole-grain consumption. This association is attenuated, but not removed, when adjustments for lifestyle and anthropometric measurements (BMI and waist circumference) are made. However, inclusion of fibre and Mg in the model removes the association, suggesting that these factors may account for some of the effect of whole grains on insulin sensitivity. To date there have been no large-scale intervention studies to confirm the beneficial effect of increasing wholegrain food consumption on insulin sensitivity. In one small intervention study in which eleven overweight and obese hyperinsulinaemic men followed a strict dietary regimen in which they ate six to ten portions of whole grains for 6 weeks lower fasting insulin concentrations and improved insulin sensitivity have been reported . This study, in a high-risk group whose intakes of wholegrain food exceeded those recommended for the general population, provides evidence of a beneficial effect but requires confirmation in the wider population at intakes that may be achievable in the general population.
Whole grains, inflammation and endothelial function
Inflammation is now recognised as a major contributor to atherosclerosis and vascular endothelial dysfunction (Ross, 1999) , although the mechanisms involved are not clear. Pro-inflammatory mediators, including cytokines such as IL-6, IL-18 and TNFa, are known to be elevated in overweight and obese individuals (Esposito et al. 2003) . These compounds may affect vascular and endothelial cells resulting in induction of adhesion molecules, oxidative stress and reduction in NO production and cell proliferation, all of which promote atherosclerosis (Haffner, 2003; Plutzky, 2003) . Endothelial dysfunction causes enhanced and maintained endothelial deactivation, resulting in elevated plasma concentrations of soluble endothelial adhesion molecules. Serum concentrations of these molecules are strongly related to CVD risk in patients without clinical symptoms of the disease (Brown & Hu, 2001 ). C-reactive protein (CRP) is an acute-phase protein secreted by the liver and is also a sensitive marker for subclinical inflammation and CVD risk (Yudkin et al. 1999; Ridker, 2001) . The link between CRP, cytokines and insulin resistance remains unclear. Liu et al. (2002) have demonstrated a positive association between plasma high-sensitivity CRP and dietary glycaemic load in 244 healthy middle-aged women from the Women's Health Study, independent of conventional risk factors for IHD. Their results suggest that perturbations in the proinflammatory process may be a mechanism whereby a high intake of rapidly-digested and absorbed carbohydrates (high GI) increases the risk of CVD. In addition, the authors have noted that the dose-response gradient between dietary glycaemic load and high-sensitivity CRP is more apparent for overweight women, thus those who are more prone to be insulin resistant may be at an even higher risk of developing this pro-inflammatory state. A further link with pro-inflammatory changes is shown in the progression from normal glucose tolerance to impaired glucose tolerance with accompanying insulin resistance in which circulating concentrations of plasminogen activator inhibitor-1 and fibrinogen are progressively increased (Festa et al. 1999) . To date there are no studies in which markers of inflammatory status or endothelial function have been compared for different whole-grain intakes. However, circumstantial evidence of an association can be drawn from a cross-sectional study of 732 women from the Nurses' Health Study cohort by Lopez-Garcia et al. (2004) . In this analysis subjects were divided according to dietary patterns; the 'prudent' pattern included whole grains whereas the 'Western' pattern included refined grains. It was found that the age-adjusted geometric-mean plasma concentrations of CRP and E-selectin show decreasing trends with increasing quintiles of the 'prudent' dietary pattern. In contrast, there are increasing trends with increasing quintiles of 'Western' dietary pattern. Further analysis of the diets from this cohort using a range of diet quality scores (Fung et al. 2005 ) also demonstrates reduced concentrations of biomarkers of inflammation and endothelial function with higher diet-quality scores for some of the scoring systems. In a larger study of subjects from the National Health and Nutrition Examination Survey 1999 Ajani et al. (2004 have shown that dietary fibre intake is inversely correlated with serum CRP concentration. Unfortunately, the authors do not report the sources of dietary fibre, so it is not possible to determine the contribution of whole grain to fibre intakes. However, since whole grains make a sizeable contribution to fibre intake it is likely that those with the higher fibre intakes will also have higher intakes of whole grains. As a result of their cross-sectional nature these studies do not establish causality, but they clearly suggest that improving diet quality with the inclusion of high-fibre wholegrain food options is a possible mechanism for reducing these important markers of CVD risk.
Whole grains and body weight
Several studies have investigated the relationship between whole-grain consumption and anthropometric measurements including body weight and BMI, or have included these variables as part of the analysis of large population-based studies. A summary of the larger of these studies is shown in Table 2 . The majority of the studies have relied on self-reported body weights and should therefore be viewed with some caution, but overall there is some evidence of a beneficial negative relationship between whole-grain intake and body weight, albeit modest. For the Nurses' Health Study, in which multiple analyses have been carried out (Liu et al. 1999 (Liu et al. , 2000a , the data are a little unclear. In one paper (Liu et al. 2000b) BMI reportedly 'did not vary appreciably across quintiles of intake' whereas in another paper (Liu et al. 2000a) 'women with high intake of whole grains . . . weighed less'. In their 10-year follow-up of the same cohort Liu et al. (2003) have shown that although BMI increases with time regardless of levels of grain intake, the increases in both body weight and BMI are less with increasing quintiles of whole-grain intake. Interestingly, for the Iowa Women's study cross-sectional data appear to suggest no relationship between whole-grain intake and BMI, albeit using different methods to categorise subjects (Table 2) . However, in an 8-year follow-up of this cohort selfreported weight gain has also been shown to be lower for those in the highest quintile of whole-grain intake compared with those in the lowest quintile of whole-grain intake at the second time point. Large changes in wholegrain intake between quintiles of intake over the same period were reported ( -14 . 2 g/d for the lowest quintile and + 23 . 8 g/d for the highest quintile), and it is not known whether there was tracking of individuals within the distribution profiles for whole-grain intake. Where similar longitudinal comparisons were made for the Nurses' Health cohort (Liu et al. 2003 ) a highly-significant (P = 0 . 02) interaction between whole-grain intake and BMI at baseline was found. Further confounding of the results may also have been introduced if the subjects not only changed their whole-grain intakes but also changed their lifestyle in line with those known to be associated with individuals who eat more whole grains ). Whilst there is limited direct evidence of the beneficial effect of whole-grain intake on body weight, there are considerable data on the effects of dietary fibre . Whether body-weight regulation is an important mechanism through which whole grains reduce CVD risk is unclear, and longer-term well-controlled randomised trials investigating this relationship are required.
Summary
Wholegrain foods are considered amongst the healthiest food choices that are available; however, their consumption remains well below the US recommended level of three servings per d (US Department of Agriculture, 2005). These recommended levels have been proposed on the basis of a growing body of epidemiological data showing strong evidence for protection against CVD, type 2 diabetes and some cancers. The mechanistic evidence to support these claims is limited, and therefore there is a need for well-controlled intervention studies to underpin the health claims and provide evidence on which to develop public health strategies to promote whole-grain consumption. In the UK the Food Standards Agency has recently commissioned two such intervention studies based in the University of Newcastle (jointly with the MRC-HNR, Cambridge, and involving Cereal Partners UK) and the University of Aberdeen (jointly with the Rowett Multivariate-adjusted weight change over 8-year follow-up was significantly lower across quintiles of whole-grain intake (+1 . 87 kg for lowest quintile, + 0 . 75 kg for highest quintile; P < 0 . 0001 for trend) Iowa Women's Health Study (baseline data from 1986) 34 492 women Significant reduction in BMI across quintiles of intake (27 . 2 kg/m 2 for lowest quintile of whole-grain intake to 26 . 9 kg/m 2 for the highest quintile; P < 0 . 0001 for trend) Jacobs et al. (1998) Significant reduction in mean waist : hip ratio across quintiles of whole-grain intake (0 . 848 for lowest quintile, 0 . 832 for highest quintile; P < 0 . 0001 for trend) Iowa Women's Health Study (baseline data from 1986 for women matched on eating 6 g total grain fibre intake/8 . 3 MJ (2000 kcal) per d) 11 040 women
No difference in BMI between group with whole-grain fibre contributing 71% of total fibre intake compared with group with refined grain fibre contributing 77% of total grain fibre intake (27 . 0 kg/m 2 and 27 . 2 kg/m 2 respectively for each group) Jacobs et al. (2000) Research Institute and Robert Gordon University) under the Diet and Cardiovascular Health Research Programme (N02). These projects are the first large-scale longer-term (16-week) interventions to be carried out using wholegrain foods that can readily be incorporated into the diet in order to meet the target levels suggested in the US Department of Agriculture (2005) dietary guidelines for Americans. For both studies outcome variables include comprehensive measures of CVD risk factors, e.g. blood lipid profiles, haemostatic and inflammatory markers, and anthropometric measures. These studies, which are expected to report by the end of 2007, will make an important contribution to the knowledge of the consequences of increased consumption of whole grains on cardiovascular risk.
